Dynamic Solution and V-Brain Sign Strategic Partnership for Commercialization of BCI and AI Robotics

From the left, Myunghun Baek, CEO of Dynamic Solution, and Giwon Lee, CEO of Y-Brain, are taking a commemorative photo after signing a memorandum of understanding (MOU) at Dynamic Solution headquarters in Gyeonggi Business Growth Center, Pangyo 2nd Techno Valley, Seongnam City on the 10th. Photo by Dynamic Solution

Dynamic Solution (formerly known as Neofect) is joining forces with the BCI specialist company V-Brain to commercialize brain-computer interface (BCI) technology. On April 15, the two companies announced the signing of a strategic business agreement (MOU) and their intention to jointly pursue brain nerve signal-based precision control technology and AI robotics integration.

This collaboration centers on developing technology that enables patients with quadriplegia to control devices with their thoughts by combining BCI and artificial intelligence (AI) robotics. At the same time, both companies aim to secure technologies for restoring visual and auditory impairments and to expand these technologies into various sectors, including wearable robots and defense and industrial robots.

The two companies have identified the following as key areas of cooperation: joint research on BCI and intelligent AI robotics control systems; collaboration on the commercialization and global expansion of BCI solutions; joint execution of national projects; and the exchange of specialized personnel and technology.

The company stated, "By combining our technological strengths, we can accelerate the timeline for BCI commercialization," adding, "We plan to focus on establishing a technological foundation that can be utilized in a wide range of industries beyond healthcare."

V-Brain is a company that offers a one-stop BCI solution, ranging from non-invasive brainwave testing to heart rate variability (HRV) analysis and automated reporting. Currently, approximately one-third of psychiatric hospitals and clinics in Korea use this platform, including 312 organizations for scale assessments, 183 for electroceuticals, and 574 for integrated management solutions, with a cumulative total of 1.41 million mental health medical data cases collected.

V-Brain is also pursuing an initial public offering (IPO). The company plans to submit a securities registration statement within this year after completing a technical evaluation and preliminary listing review in the first half of 2026, with a goal of listing on KOSDAQ in the first quarter of next year. Following the largest shareholder, Ceragem, Dynamic Solution has joined as the second-largest shareholder.

The company is also noted for its technological competitiveness. V-Brain was selected as the sole company in the BCI sector for the national strategic project "K-Moonshot." In a recent official event attended by the Minister of Science and ICT, the company demonstrated the feasibility of commercialization through a technology demonstration. Major institutions participating in this project include LG AI Research, SK Telecom, Naver Cloud, NC AI, KT, LG Uplus, Korea Institute of Science and Technology (KIST), Electronics and Telecommunications Research Institute (ETRI), and Korea Institute of Science and Technology Information (KISTI), with a total of 600 billion won in government funding to be invested. Dynamic Solution is also seeking to join the consortium through this collaboration.

V-Brain, together with Professor Cho Ilju's team at Korea University, is also developing a high-density wireless BCI system capable of reading 512-channel brainwaves. The team is focusing on implementing technology that achieves high resolution without opening the skull by utilizing a partial brain implantation method.

Dynamic Solution aims to enter the global market by combining its own brainwave data transmission technology with V-Brain's scanning technology. The company has been conducting BCI research since the early 2010s, and in 2021 succeeded in developing trial technology through a Korea-Germany BCI consortium with Seoul National University Bundang Hospital. Currently, the company is pursuing research and development for BCI intelligence and commercialization, targeting the period from September 2025 to August 2028.

CEO Myunghun Baek said, "Through our collaboration with V-Brain, we will improve the completeness of BCI technology and accelerate its commercialization," adding, "We will actively push into both domestic and international healthcare and industrial markets." He continued, "We will also continue to discuss partnerships with global companies to secure technological reliability and expand our role within a stable supply chain."

This content was produced with the assistance of AI translation services.